|
2022
|
P/S
|
Pharmaceuticals. |
|
|
P/S
|
Pharmaceutical preparations for use in oncology |
|
|
P/S
|
Pharmaceutical preparations for use in oncology |
|
2020
|
Invention
|
Combination comprising hdac inhibitor, ctla-4 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor f... |
|
|
Invention
|
Kv1.3 inhibitors and their medical application.
Disclosed are compounds within the scope of form... |
|
|
Invention
|
Kv1.3 inhibitors and their medical application.
Compounds of formula (II) or a pharmaceutically ... |
|
2019
|
Invention
|
Kv1.3 inhibitors and their medical applications.
The present invention relates to a compound of ... |
|
|
Invention
|
Combination comprising hdac inhibitor, lag-3 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor fo... |
|
|
Invention
|
Pharmaceutical combination products comprising a histone deacetylase (hdac) inhibitor and a tlr7 ... |
|
|
Invention
|
Combinations including a cpg-c type oligonucleotide and a histone deacetylase inhibitor for treat... |
|
|
Invention
|
Combination comprising hdac inhibitor and cd137 agonist for cancer therapy. The invention relates... |
|
|
Invention
|
Kv1.3 inhibitors and their medical application. Compounds of formula (II) or a pharmaceutically a... |
|
2018
|
Invention
|
Hdac inhibitor in combination with immune checkpoint modulator for cancer therapy.
The invention... |
|
|
Invention
|
Hdac inhibitor in combination with immune checkpoint modulator for cancer therapy. The invention ... |
|
|
Invention
|
Hdac inhibitor in combination with antimetabolite agent for cancer therapy. The invention relates... |
|
|
Invention
|
Method of inhibiting dyrk1b. The present invention relates to a DYRK1B inhibitor for use in the t... |
|
2017
|
Invention
|
Medical application of resminostat in asian patients. The invention relates to medical applicatio... |
|
|
Invention
|
Hdac inhibitor in combination with vegf/vegfr interaction for cancer therapy based on platelet co... |
|
|
Invention
|
Hdac inhibitor in combination with vegf / vegfr interaction inhibitor for cancer therapy based on... |
|
|
Invention
|
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmunein... |
|
2016
|
Invention
|
(e)-n-(2-aminophenyl)-3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfonyl)-1h-pyrrol-3-yl)acrylami... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment or prevention of inflammatory diseas... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical
preparations for the treatment of can... |
|
|
Invention
|
Treatment and prevention of viral diseases with 2,3-dihydrobenzofuran-5-yl compounds. The inventi... |
|
|
Invention
|
Kv1.3 inhibitors and their medical applications. The present invention relates to a compound of t... |
|
|
Invention
|
Kv1.3 inhibitors and their medical application. The present invention relates to a compound of th... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations f... |
|
2014
|
Invention
|
2,3-dihydrobenzofuran-5yl compounds as dyrk kinase inhibitors. 1, and A, as well as the variables... |
|
|
Invention
|
2,3-dihydrobenzofuran-5-yl compounds as dyrk kinase inhibitors.
The present invention ... |
|
|
Invention
|
Method of inhibiting dyrk1b.
The present invention relates to a DYRK1B inhibitor ... |
|
|
Invention
|
Gene expression biomarkers and their use for diagnostic and prognostic application in patients po... |
|
2012
|
Invention
|
Sulfonylpyrroles. Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have... |
|
2011
|
Invention
|
Novel heterocyclic nf-kb inhibitors.
The present invention relates in one embodiment to compound... |
|
|
Invention
|
Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
The present in... |
|
|
Invention
|
Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory age... |
|
|
Invention
|
Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents. The present inv... |
|
|
Invention
|
Benzazole analogues and uses thereof.
The present invention relates to compounds of the general ... |
|
|
Invention
|
Inhibitors of cancer cell, t-cell and keratinocyte proliferation.
The invention relates to compo... |
|
2009
|
Invention
|
Combinational therapy for treating autoimmune disease.
The present invention relates to the trea... |
|
|
Invention
|
N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds. Compounds of a certai... |
|
2002
|
P/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
